No increased risk for infections with thiopurine-induced leukopenia in inflammatory bowel disease patients without a variant in thiopurine S-methyltransferase

被引：0

作者：

Broekman, M. ^{[1
]}

Coenen, M. ^{[2
]}

van Marrewijk, C. ^{[2
]}

Wanten, G. ^{[1
]}

Derijks, L. ^{[3
]}

Vermeulen, S. ^{[2
,4
]}

Wong, D. ^{[5
]}

Klungel, O. ^{[6
]}

Verbeek, A. ^{[4
]}

Hooymans, P. ^{[5
]}

Scheffer, H. ^{[2
]}

Guchelaar, H. -J. ^{[7
]}

de Jong, D. ^{[1
]}

机构：

[1] Radboud Univ Nijmegen Med Ctr, Dept Gastroenterol, Nijmegen, Netherlands

[2] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands

[3] Maxima Med Ctr Loc Veldhoven, Dept Gastroenterol & Hepatol, Veldhoven, Netherlands

[4] Radboud Univ Nijmegen Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands

[5] Zuyderland Med Ctr, Dept Clin Pharm Pharmacol & Toxicol, Sittard, Netherlands

[6] Univ Utrecht, Dept Pharmacoepidemiol & Clin Pharmacotherapy, Utrecht, Netherlands

[7] Leiden Univ Med Ctr, Dept Clin Pharm & Toxicol, Leiden, Netherlands

来源：

JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P305

引用

页码：S247 / S247

页数：1

共 50 条

[21] Genetic predisposition and thiopurine-induced pancreatitis in inflammatory bowel disease patients
Burnet, G.
de Suray, N.
De Vroey, B.
Hoang, P.
Coche, J. -C.
Denis, M.
Gala, J. -L.
Dewit, O.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S467 - S467
[22] Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
Ribaldone, Davide Giuseppe
Adriani, Alessandro
Caviglia, Gian Paolo
De Nicolo, Amedeo
Agnesod, Danilo
Simiele, Marco
Rigano, Danila
Pellicano, Rinaldo
Canaparo, Roberto
Di Perri, Giovanni
D'Avolio, Antonio
Luzza, Francesco
Abenavoli, Ludovico
Saracco, Giorgio Maria
Astegiano, Marco
MEDICINA-LITHUANIA, 2019, 55 (08):
[23] Frequency of serious adverse events of thiopurine treatment in normal thiopurine S-methyltransferase genotype children with inflammatory bowel disease
Tarnok Andras
ORVOSI HETILAP, 2019, 160 (05) : 179 - 185
[24] Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease
Wong, D. R.
Coenen, M. J. H.
Derijks, L. J. J.
Vermeulen, S. H.
van Marrewijk, C. J.
Klungel, O. H.
Scheffer, H.
Franke, B.
Guchelaar, H. -J.
de Jong, D. J.
Engels, L. G. J. B.
Verbeek, A. L. M.
Hooymans, P. M.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (03) : 391 - 402
[25] Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
El-Matary, Wael
CROHNS & COLITIS 360, 2020, 2 (03)
[26] Thiopurine-induced pancreatitis in inflammatory bowel diseases
Ledder, Oren
Lemberg, Daniel A.
Day, Andrew S.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (04) : 399 - 403
[27] Thiopurine-induced liver injury in patients with inflammatory bowel disease:: A systematic review
Gisbert, Javier P.
Gonzalez-Lama, Yago
Mate, Jose
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (07): : 1518 - 1527
[28] Thiopurine S-Methyltransferase Gene Polymorphisms in a Healthy Slovak Population and Pediatric Patients with Inflammatory Bowel Disease
Chocholova, Alica
Soltysova, Andrea
Minarik, Gabriel
Cierna, Iveta
Sufliarska, Sabina
Mladosievicova, Beata
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2013, 32 (05): : 239 - 246
[29] Effects of aminosalicylates on thiopurine S-methyltransferase activity:: an ex vivo study in patients with inflammatory bowel disease
Xin, H
Fischer, C
Schwab, M
Klotz, U
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (09) : 1105 - 1109
[30] GENETIC BACKGROUND OF THIOPURINE-INDUCED PANCREATITIS IN JAPANESE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Kakuta, Yoichi
Kawai, Yosuke
Naito, Takeo
Onodera, Motoyuki
Moroi, Rintaro
Kanazawa, Yoshitake
Kuroha, Masatake
Shiga, Hisashi
Khor, Seik-Soon
Tokunaga, Katsushi
Nagasaki, Masao
Kinouchi, Yoshitaka
Masamune, Atsushi
GASTROENTEROLOGY, 2019, 156 (06) : S1114 - S1115

← 1 2 3 4 5 →